Autor

Nome:
Carlos Gouveia Pinto
Habilitações:
Doutoramento: UTL, Economics, 1988
Licenciatura: UTL, Economics, 1973
e-mail:
gpinto@iseg.utl.pt
URL:
http://www.iseg.utl.pt/docentes/docentes.php?qual=1063
Instituição REBIDES:
Universidade de Lisboa - Instituto Superior de Economia e Gestão (2013)
Artigos 6:
Ranking: CEF.UP+NIPE (average of all rankings) (2012).

Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy 1.13
Ana Teresa Paquete, Luis Silva Miguel, Ursula Becker, Catarina Pereira, Carlos Gouveia Pinto
Applied Health Economics And Health Policy, vol. 15, 2017, p. 501-512.

Colorectal Cancer in Portugal 4.92
Carlos Gouveia Pinto, Ana Teresa Paquete, Irene Pissarra
European Journal Of Health Economics, vol. 10, 2010, p. 65-73.

Health Care Reform in Portugal: An Evaluation of the NHS Experience 15.73
Monica Duarte Oliveira, Carlos Gouveia Pinto
Health Economics, vol. 14, 2005, p. 203-220.

Pricing and Reimbursement of Pharmaceuticals in Portugal 7.38
Carlos Gouveia Pinto, Inês Teixeira
European Journal Of Health Economics, vol. 3, 2002, p. 267-270.

Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries 3.74
Carlos Gouveia Pinto, A. Lafuma, F. Fagnani, M.J.C. Nuijten, G. Berdeaux
Pharmacoeconomics, vol. 19, 2001, p. 255-265.

A Signalling Theory of Excessive Technological Adoption 2.37
Pedro Pita Barros, Carlos Gouveia Pinto, Ana Machado
Health Care Management Science, vol. 2, 1999, p. 117-123.

Voltar